Back to Search
Start Over
Subolesin knockdown in tick cells provides insights into vaccine protective mechanisms.
- Source :
-
Vaccine . Apr2024, Vol. 42 Issue 11, p2801-2809. 9p. - Publication Year :
- 2024
-
Abstract
- • Multi-omics analysis of effect of Subolesin knockdown on the regulome of tick cells. • Results support a key role for Subolesin in the tick cell regulome. • Differential proteins provide insights into vaccine protective mechanisms. • Differential proteins suggest candidate tick protective antigens. Ticks as obligate blood-feeding arthropod vectors of pathogenic viruses, bacteria, protozoa and helminths associated with prevalent tick-borne diseases (TBDs) worldwide. These arthropods constitute the second vector after mosquitoes that transmit pathogens to humans and the first vector in domestic animals. Vaccines constitute the safest and more effective approach to control tick infestations and TBDs, but research is needed to identify new antigens and improve vaccine formulations. The tick protein Subolesin (Sub) is a well-known vaccine protective antigen with a highly conserved sequence at both gene and protein levels in the Ixodidae and among arthropods and vertebrates. In this study, transcriptomics and proteomics analyses were conducted together with graph theory data analysis in wild type and Sub knockdown (KD) tick ISE6 cells in order to identify and characterize the functional implications of Sub in tick cells. The results support a key role for Sub in the regulation of gene expression in ticks and the relevance of this antigen in vaccine development against ticks and TBDs. Proteins with differential representation in response to Sub KD provide insights into vaccine protective mechanisms and candidate tick protective antigens. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0264410X
- Volume :
- 42
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Vaccine
- Publication Type :
- Academic Journal
- Accession number :
- 176586604
- Full Text :
- https://doi.org/10.1016/j.vaccine.2024.03.006